Pharming Group N.V. (PHGUF)

Pharming Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,079	650	763	756	572	993
Market Cap Growth	83.64%	-14.84%	0.93%	32.18%	-42.41%	-10.20%
Enterprise Value	1,043	608	728	702	554	963
Last Close Price	2.15	0.98	1.18	1.15	0.87	1.54
PE Ratio	2824.02	-	-	55.27	35.75	26.30
PS Ratio	2.98	2.19	3.11	3.68	2.88	4.68
PB Ratio	4.08	2.94	3.49	3.69	2.96	5.41
P/TBV Ratio	8.32	4.06	5.17	5.82	5.23	10.47
P/FCF Ratio	20.46	-	-	35.85	21.10	12.57
P/OCF Ratio	20.23	-	-	33.66	15.11	11.87
EV/Sales Ratio	2.85	2.05	2.97	3.41	2.78	4.54
EV/EBITDA Ratio	20.42	188.69	-	40.97	18.22	11.66
EV/EBIT Ratio	25.35	-	-	67.70	23.07	12.62
EV/FCF Ratio	19.79	-	-	33.29	20.43	12.19
Debt / Equity Ratio	0.50	0.51	0.78	0.82	0.84	0.88
Debt / EBITDA Ratio	2.55	17.02	-	8.46	4.88	1.92
Debt / FCF Ratio	2.48	-	-	7.91	5.97	2.05
Asset Turnover	0.81	0.69	0.55	0.50	0.49	0.63
Inventory Turnover	0.57	0.63	0.51	0.50	0.87	1.26
Quick Ratio	2.39	2.96	3.28	3.90	4.69	3.09
Current Ratio	3.16	3.77	4.06	4.65	5.33	3.43
Return on Equity (ROE)	0.03%	-5.38%	-4.98%	6.88%	8.50%	25.09%
Return on Assets (ROA)	5.76%	-0.52%	-3.06%	1.57%	3.68%	14.13%
Return on Invested Capital (ROIC)	0.08%	-2.10%	-12.76%	5.79%	10.98%	54.07%
Return on Capital Employed (ROCE)	10.70%	-1.10%	-5.70%	2.80%	6.80%	22.30%
Earnings Yield	0.04%	-1.82%	-1.38%	1.81%	2.80%	3.80%
FCF Yield	4.89%	-0.40%	-2.46%	2.79%	4.74%	7.95%
Buyback Yield / Dilution	2.65%	-2.18%	7.09%	-0.85%	-2.70%	-1.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.